Biosymtec® Technologies, Inc.
Telehealth/Telemedicine Product Research
Manufacturing, Marketing and Licensing
There are at least 45 million patients in the U.S. with COPD (emphysema and chronic bronchitis), moderate to severe asthma, bronchiectasis, heart failure and cystic fibrosis.   Nearly two-thirds of COPD hospitalizations are caused by infections,
infections which should have been dealt with sooner.   The patients waited too long.

Our associate, Dr. James A. Wilson (Ret.), Family Medicine Specialist says, "I almost never prescribed an antiviral drug for influenza, because patients would come into the office too late for the drug to be effective."

Most people also wait too long before using a telehealth system when an illness is developing.

 
Problem Solved. Here is a product, ideal for those with chronic respiratory conditions, such as COPD and asthma, which will tell patients when it is important to contact their healthcare providers for a televisit.   The Biosymtec Monitor detects respiratory and non-respiratory infections days before symptoms or clinical signs such as a fever.

Used upon waking, the patient on the right placed the dual sensing probes under her tongue, straddling the frenulum, with her lips over the mouthpiece, locating the sensing probes in the precise X, Y and Z planes.   She then pressed a single button on the device.   If an EKG was required, she simply held down the button for a few more seconds.   She then stood, blew hard and long through the monitor.   The Biosymtec embedded AI algorithm (called Aila™) then analyzed the data obtained, and displayed the results on her monitor.   Today, she sees the orange and red segments on the display and knows she must televisit with her healthcare provider.
And for patients with Heart Failure, and other chronic conditions in which any infection is a serious concern, we have the
Biosymtec Health Monitoring Alarm Clock.
It uses the Biosymtec embedded AI algorithm (Aila™) to predict any impending infection up to two or more days before you experience symptoms or clinical signs such as a fever.

How does it do that? First you apply a comfortable, non-invasive, accurate, wireless thermometer by GreenTEG's CALERA® Research (just as the patient is doing on the right).   That will allow your Health-Monitoring Alarm Clock to monitor you for developing infections.   As long as you wear the wireless thermometer, there is nothing more for you to do.   At the time you have set the alarm to wake you in the morning, the nurse on the display will tell you whether you have to be concerned about an infection and call to schedule a televisit with your provider.
For those who are mostly "homebound" or those who need frequent, more in depth telehealth visits due to a chronic condition, we have the Biosymtec Telekit™ which includes:
  1. A large display screen to see your healthcare provider,
  2. A basic keyboard to answer preloaded health questions in advance of the televisit,
  3. A multi-function camera (Camometer™),
  4. Graphing software to record a 50-day history of health data,
  5. A built in cuff-type blood pressure monitor, often needed during televisit exams,
  6. Storage space for the Camometer, an otoscope and a digital stethoscope.

The Biosymtec Camometer is wireless and rechargeable. It includes an HD video camera, an exam light source, a microphone and an IR thermometer.

The Camometer also recharges wirelessly when mounted on the back of the display where it is secured magnetically.
CONTACT



    Name
    Title
    Company
    Email

    Subject:    

   

Seeking a President & CEO

Biosymtec Technologies, Inc. is a company created to provide, to those patients who wish to use telehealth services with their healthcare provider, products which will make their remote visits more prepared and more natural. Patients with chronic diseases more frequently require telehealth services, including those with COPD, moderate to severe asthma, bronchiectasis, heart failure and cystic fibrosis; approximately 45 million in the U.S. and over 300 million worldwide.

Beiswenger and Associates is seeking a President & CEO to launch Biosymtec Technologies, Inc.. The company has been incorporated in Pennsylvania, a Business Plan has been prepared, a Finacial Spreadsheet developed ($50 million in Sales forecasted in year three) and a Pitch Deck created. Beiswenger and Associates will provide product and technical support.

An investor has been identified to fund the launch ($6 Milllion in two tranches of $3 million), but requires first to meet the CEO and to see the completion of a prototype Biosymtec Monitor. John Beiswenger, CEO of Bioswenger and Associates, and the President of Biosymtec Technologies, will work together to raise the funds for the development of the prototype, which will be completed by an associate medical product development firm, already briefed on the project.

The President, chosen for Biosymtec Technologies, will have some medical product experience and will be expected to pull together a management team including marketing personnel. If interested, contact John Beiswenger through the Beiswenger.com website or through this website.

The Biosymtec embedded AI algorithm (Aila™) used in the Biosymtec Monitor and the Clock is the property of Beiswenger and Associates, Inc. and was created, and the software written by John Beiswenger, CTO.   The algorithm was tested through pre-clinical trials in Hong Kong (5 health clinics), Tianjin China (Tianjin Haihe Hospital), and an IRB Approved Research Study in Pennsylvania at a church community.   The results of all sites were combined and analyzed by the Study Physician, and the accuracy of the Algorithm was determined to be: Sensitivity 96.7% and Specificity 96.8%.

Final Design and prototyping of the Biosymtec Monitor, the Biosymtec TeleKit™ and the Biosymtec Health-Monitoring Alarm Clock will be completed by a qualified medical product design firm, an associate of Beiswenger and Associates, Inc.

 
© 2024 Beiswenger Associates, Inc.